DOW JONES21,158.50-758.66 -3.46%
S&P 5002,487.84-96.75 -3.74%
NASDAQ7,420.63-279.47 -3.63%

JP Morgan Maintains Neutral on ACADIA Pharmaceuticals, Lowers Price Target to $33

JP Morgan maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and lowers the price target from $35 to $33.

Benzinga · 03/02/2020 14:01

JP Morgan maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and lowers the price target from $35 to $33.